Spots Global Cancer Trial Database for Coxib-inhibition of Duodenal Polyp Growth in FAP
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Coxib-inhibition of Duodenal Polyp Growth in FAP
Official Title: Coxib-inhibition of Duodenal Polyp Growth in Familial Adenomatous Polyposis
Study ID: NCT00844727
Conditions
Study Description
Brief Summary: Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Dept of Medicine, Rikshospitalet, Oslo, , Norway
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
